Skip to main content

What the FDA labels say about taking them together

Ioflupane i 123 and paroxetine

Ioflupane i 123's FDA label of April 24, 2026 names paroxetine in its drug interactions section; the paroxetine labels PlainMeds reads (4) do not name ioflupane i 123. The ioflupane i 123 label: “Selective serotonin reuptake inhibitors may increase or decrease ioflupane binding to the dopamine transporter.”

Check it at the source: the ioflupane i 123 FDA label on DailyMed (effective April 24, 2026, Medi-Physics Inc. dba GE Healthcare.); the paroxetine FDA label on DailyMed (effective February 12, 2026, Mylan Pharmaceuticals Inc.).

What does the ioflupane i 123 label say about paroxetine?

Ioflupane i 123 label, drug interactions

Selective serotonin reuptake inhibitors (paroxetine and citalopram) may increase or decrease ioflupane binding to the dopamine transporter.

Source: FDA drug label (DaTscan), NDA022454 (Ge Hlthcare Inc), as published by Medi-Physics Inc. dba GE Healthcare., effective April 24, 2026 (SPL set ef7804d7-c691-495b-8aaf-5bc54fd5d9f6), via openFDA; the full label on DailyMed

What does the paroxetine label say about ioflupane i 123?

Paroxetine's label (effective February 12, 2026) and its 3 other brand-application labels do not name ioflupane i 123 in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Paroxetine), Mylan Pharmaceuticals Inc., effective February 12, 2026 (SPL set 89dd7e24-85fc-4152-89ea-47ec2b48a1ed), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

1Ioflupane i 123 generic labelers
45Paroxetine generic labelers
Ioflupane i 123Paroxetine
Labeled forn/aDepression, Anxiety, Menopause symptoms
Boxed warningNoYes
Pharmacy cost (NADAC)n/a$0.0611 per tablet 20 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?